114 related articles for article (PubMed ID: 11392536)
1. Synthesis and evaluation of a difluoromethylene analogue of sphingomyelin as an inhibitor of sphingomyelinase.
Yokomatsu T; Takechi H; Akiyama T; Shibuya S; Kominato T; Soeda S; Shimeno H
Bioorg Med Chem Lett; 2001 May; 11(10):1277-80. PubMed ID: 11392536
[TBL] [Abstract][Full Text] [Related]
2. Sphingomyelin analogues as inhibitors of sphingomyelinase.
Taguchi M; Sugimoto K; Goda K; Akama T; Yamamoto K; Suzuki T; Tomishima Y; Nishiguchi M; Arai K; Takahashi K; Kobori T
Bioorg Med Chem Lett; 2003 Jun; 13(12):1963-6. PubMed ID: 12781174
[TBL] [Abstract][Full Text] [Related]
3. Biological evaluation of sphingomyelin analogues as inhibitors of sphingomyelinase.
Taguchi M; Goda K; Sugimoto K; Akama T; Yamamoto K; Suzuki T; Tomishima Y; Nishiguchi M; Arai K; Takahashi K; Kobori T
Bioorg Med Chem Lett; 2003 Nov; 13(21):3681-4. PubMed ID: 14552757
[TBL] [Abstract][Full Text] [Related]
4. [Synthesis of sphingomyelin analogues as a sphingomyelinase inhibitor and the application as a blocking agent of extracellular stress signaling].
Tsuji Y; Soeda S; Ochiai T; Mishima K; Iwasaki K; Fujiwara M; Yokomatsu T; Murano T; Akiyama T; Shibuya S; Shimeno H
Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):67P-69P. PubMed ID: 12491783
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of a nitrogen analogue of sphingomyelin as a sphingomyelinase inhibitor.
Hakogi T; Taichi M; Katsumura S
Org Lett; 2003 Aug; 5(16):2801-4. PubMed ID: 12889878
[TBL] [Abstract][Full Text] [Related]
6. Stereocontrolled synthesis of a sphingomyelin methylene analogue as a sphingomyelinase inhibitor.
Hakogi T; Monden Y; Iwama S; Katsumura S
Org Lett; 2000 Aug; 2(17):2627-9. PubMed ID: 10990413
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of sphingomyelin sulfur analogue and its behavior toward sphingomyelinase.
Hakogi T; Fujii S; Morita M; Ikeda K; Katsumura S
Bioorg Med Chem Lett; 2005 Apr; 15(8):2141-4. PubMed ID: 15808485
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiapoptotic activity of a novel analogue of the neutral sphingomyelinase inhibitor scyphostatin.
Claus RA; Wüstholz A; Müller S; Bockmeyer CL; Riedel NH; Kinscherf R; Deigner HP
Chembiochem; 2005 Apr; 6(4):726-37. PubMed ID: 15751001
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of non-competitive inhibitors of sphingomyelinases with significant activity.
Yokomatsu T; Murano T; Akiyama T; Koizumi J; Shibuya S; Tsuji Y; Soeda S; Shimeno H
Bioorg Med Chem Lett; 2003 Jan; 13(2):229-36. PubMed ID: 12482429
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of sphingomyelin carbon analogues as sphingomyelinase inhibitors.
Hakogi T; Monden Y; Taichi M; Iwama S; Fujii S; Ikeda K; Katsumura S
J Org Chem; 2002 Jul; 67(14):4839-46. PubMed ID: 12098296
[TBL] [Abstract][Full Text] [Related]
11. Diastereoselective synthesis of gamma-amino-delta-hydroxy-alpha,alpha-difluorophosphonates: a vehicle for structure-activity relationship studies on SMA-7, a potent sphingomyelinase inhibitor.
Yamagishi T; Muronoi S; Hikishima S; Shimeno H; Soeda S; Yokomatsu T
J Org Chem; 2009 Aug; 74(16):6350-3. PubMed ID: 19610607
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of acidic sphingomyelinase by xanthone compounds isolated from Garcinia speciosa.
Okudaira C; Ikeda Y; Kondo S; Furuya S; Hirabayashi Y; Koyano T; Saito Y; Umezawa K
J Enzyme Inhib; 2000; 15(2):129-38. PubMed ID: 10938539
[TBL] [Abstract][Full Text] [Related]
13. Manumycin A and its analogues are irreversible inhibitors of neutral sphingomyelinase.
Arenz C; Thutewohl M; Block O; Waldmann H; Altenbach HJ; Giannis A
Chembiochem; 2001 Feb; 2(2):141-3. PubMed ID: 11828438
[No Abstract] [Full Text] [Related]
14. Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima: taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties.
Nara F; Tanaka M; Hosoya T; Suzuki-Konagai K; Ogita T
J Antibiot (Tokyo); 1999 Jun; 52(6):525-30. PubMed ID: 10470675
[TBL] [Abstract][Full Text] [Related]
15. Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties.
Figuera-Losada M; Stathis M; Dorskind JM; Thomas AG; Bandaru VV; Yoo SW; Westwood NJ; Rogers GW; McArthur JC; Haughey NJ; Slusher BS; Rojas C
PLoS One; 2015; 10(5):e0124481. PubMed ID: 26010541
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase.
Arenz C; Gartner M; Wascholowski V; Giannis A
Bioorg Med Chem; 2001 Nov; 9(11):2901-4. PubMed ID: 11597471
[TBL] [Abstract][Full Text] [Related]
17. Identification and evaluation of neutral sphingomyelinase 2 inhibitors.
Lee DH; Kim SH; Ahn KH; Kim SK; Choi JM; Ji JE; Won JH; Park YH; Lim C; Kim S; Kim DK
Arch Pharm Res; 2011 Feb; 34(2):229-36. PubMed ID: 21380806
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of sphingomyelinase activity helps to prevent neuron death caused by ischemic stress.
Soeda S; Tsuji Y; Ochiai T; Mishima K; Iwasaki K; Fujiwara M; Yokomatsu T; Murano T; Shibuya S; Shimeno H
Neurochem Int; 2004 Oct; 45(5):619-26. PubMed ID: 15234103
[TBL] [Abstract][Full Text] [Related]
19. Development of carbohydrate-derived inhibitors of acid sphingomyelinase.
Roth AG; Redmer S; Arenz C
Bioorg Med Chem; 2010 Jan; 18(2):939-44. PubMed ID: 20005726
[TBL] [Abstract][Full Text] [Related]
20. Degradation of fluorescent and radiolabelled sphingomyelins in intact cells by a non-lysosomal pathway.
Levade T; Vidal F; Vermeersch S; Andrieu N; Gatt S; Salvayre R
Biochim Biophys Acta; 1995 Oct; 1258(3):277-87. PubMed ID: 7548198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
